Mirae Asset Global Investments
KRON

Mirae Asset Global Investments’s Kronos Bio KRON Stock Holding History

Mirae Asset Global Investments’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,877
Closed -$60K – 2566
2022
Q3 		$60K Buy
17,877
+5,240
+41% +$23.7K ﹤0.01% 2567
2022
Q2 		$46K Buy
+12,637
New +$57.3K ﹤0.01% 2387

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Mirae Asset Global Investments's KRON Position: Q4 2022 in Review

Mirae Asset Global Investments sold out of Kronos Bio (KRON) in Q4 2022, closing a stake of 17,877 shares — an estimated $60K sold.

Mirae Asset Global Investments first reported a position in KRON in Q2 2022 and held it in 2 quarters. The position peaked at $60K in Q3 2022. 97 funds tracked by Wall St. Rank hold KRON as of Q4 2022.

  • Mirae Asset Global Investments reported no remaining Kronos Bio position as of Q4 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 17,877 Kronos Bio shares in Q4 2022, an estimated $60K.
  • Mirae Asset Global Investments first reported a position in Kronos Bio in Q2 2022 and held it in 2 quarters.
  • Mirae Asset Global Investments's Kronos Bio position peaked at $60K in Q3 2022.
  • 97 funds tracked by Wall St. Rank held Kronos Bio as of Q4 2022.

Based on Mirae Asset Global Investments's 13F filing for Q4 2022, filed 9 Feb 2023.